UTI Form 144: 15,000 Shares Planned Sale

UTI filed a Form 144 reporting the intended sale of up to 15,000 shares of Common Stock on or about 05/11/2026 on the NYSE.

Rhea-AI Filing Summary

UTI filed a Form 144 reporting the intended sale of up to 15,000 shares of Common Stock on or about 05/11/2026 on the NYSE. The filing lists multiple previously granted stock awards by date with specific award share counts, each described as Stock Award from the issuer.

Insights

Corporate Governance Analyst

Form 144 shows a planned sale of 15,000 shares and lists compensation awards by grant date.

The filing reports an intended sale of 15,000 shares with a trade date of 05/11/2026 on the NYSE. It also enumerates award grants dated 02/27/2008, 02/22/2012, 02/20/2013, 04/08/2014, 02/27/2025, and 06/05/2025 with listed share amounts.

Cash‑flow treatment and the seller's identity beyond the broker address are not stated in the excerpt; subsequent SEC filings may show whether the sales are routine dispositions tied to compensation or separate holder sales.

Key Figures

Planned sale: 15,000 shares Dollar figure shown: $536,100.00 Listed numeric figure: 55,061,381 +5 more

8 metrics

Planned sale 15,000 shares trade date <date>05/11/2026</date> on <b>NYSE</b>

Dollar figure shown $536,100.00 number appears in excerpt (labeling not explicit)

Listed numeric figure 55,061,381 numeric field adjacent to other header data (05/11/2026 row)

Award - 02/27/2008 1,250 shares Stock Award granted 02/27/2008 (compensation)

Award - 02/22/2012 3,682 shares Stock Award granted 02/22/2012 (compensation)

Award - 02/20/2013 1,863 shares Stock Award granted 02/20/2013 (compensation)

Award - 04/08/2014 3,892 shares Stock Award granted 04/08/2014 (compensation)

Award - 02/27/2025 3,599 shares Stock Award granted 02/27/2025 (compensation)

Key Terms

Form 144, Stock Award, Issuer

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Award financial

"02/27/2008 | Stock Award | Issuer"

Issuer legal

"Stock Award | Issuer | | | 1250"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does UTI's Form 144 indicate about the planned sale?

It indicates an intended sale of 15,000 shares on 05/11/2026 on the NYSE. The form lists the broker address and trade date; it also itemizes prior stock award grant dates and share amounts tied to the securities reported.

Who is listed as the broker for the transaction in UTI's filing?

Northern Trust at 2398 E. Camelback Rd., Suite 1100, Phoenix, AZ is listed. The excerpt provides the broker address but does not identify the selling individual or entity beyond that broker reference.

Are the shares being sold from compensation awards or from other holdings?

The filing lists multiple entries labeled "Stock Award" with grant dates and share counts. Those award lines appear in the securities table; the excerpt does not explicitly state which specific lots will be sold.

What award grant amounts are shown in the Form 144 excerpt?

The excerpt shows award share amounts of 1,250; 3,682; 1,863; 3,892; 3,599; and 714 shares. Each is tied to a grant date between 2008 and 2025 and labeled as "Stock Award" by the issuer.

Does the filing show UTI's outstanding shares or aggregate value?

The excerpt includes the number 55,061,381 alongside a dollar figure of $536,100.00. The filing text does not explicitly label those figures as outstanding shares or aggregate proceeds in the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 08:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001193863
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	UNIVERSAL TECHNICAL INSTITUTE INC
SEC File Number	001-31923
Address of Issuer	4225 EAST WINDROSE DRIVE SUITE 200 PHOENIX ARIZONA 85032
Phone	623-445-9500
Name of Person for Whose Account the Securities are To Be Sold	SRERE LINDA J
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock, $0.0001 par value	Northern Trust 2398 E. Camelback Rd., Suite 1100 Phoenix AZ 85016	15000	536100.00	55061381	05/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock, $0.0001 par value	02/27/2008	Stock Award	Issuer			1250	02/27/2008	Compensation
Common Stock, $0.0001 par value	02/22/2012	Stock Award	Issuer			3682	02/22/2012	Compensation
Common Stock, $0.0001 par value	02/20/2013	Stock Award	Issuer			1863	02/20/2013	Compensation
Common Stock, $0.0001 par value	04/08/2014	Stock Award	Issuer			3892	04/08/2014	Compensation
Common Stock, $0.0001 par value	02/27/2025	Stock Award	Issuer			3599	02/27/2025	Compensation
Common Stock, $0.0001 par value	06/05/2025	Stock Award	Issuer			714	06/05/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	05/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christopher Kevane, Attorney-in-Fact for Linda J. Srere
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)